Pay in 4 interest-free payments of $6.76 Learn more
Ships within 48 hours · Estimated delivery Jul 27 - Aug 1
Its potential use has revolutionized the world of researchers
Baseline bloodwork CBC, CRP, ferritin, IL-6, cortisol AM, metabolic panel, thyroid function Cardiovascular assessment heart rate variability, orthostatic vitals if POTS is suspected Gut health markers stool testing, zonulin, calprotectin if GI symptoms are prominent Mitochondrial function proxies lactate, organic acids panel if PEM is a primary complaint From there, a typical protocol might be structured as: Phase 1 (Weeks 16): Immune and gut foundation Thymosin Alpha-1: 1.6 mg subcutaneous, twice weekly BPC-157: 250500 mcg daily, route determined by predominant symptom (oral for gut, injectable for systemic) Phase 2 (Weeks 412): Tissue repair and cardiovascular recovery TB-500: 2.02.5 mg subcutaneous, twice weekly Continue BPC-157 as indicated Phase 3 (Weeks 816): Maintenance and metabolic support Taper or pulse doses based on clinical response Add mitochondrial support if fatigue persists (see: Mitochondrial Peptides and Insulin Resistance) These are illustrative dosing ranges based on clinical research and published protocols
Cancer Strong evidence shows higher NNMT in all gastric cancers, plus pancreatic, kidney, and bladder types
Retrieved November 4, 2011
The bloating you experience after meals, the fatigue that doesnt match your lifestyle, and the brain fog that makes daily tasks harder are all interconnected through the same underlying process
US$ 25.82
US$ 27.26
US$ 22.84
US$ 25.77
US$ 24.46